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Abstract
Prescription opioid abuse in the United States is an alarming health issue. In 2015,
approximately 2 million people abused prescription opioids, and 12 million individuals
misused their prescription opioid pain relievers. The percentage of individuals who died
as a result of opiate abuse increased from 22% in 2013 to 76% in 2014. The purpose of
this project was to evaluate the influence of an inner-city drug treatment (DTBF) program
on opioid users’ behavior. The practice question addressed whether knowledge of signs
and symptoms of opioid withdrawal obtained from the DTBF program resulted in a
significant behavioral change in opioid use in 45 adults ages 18 to 25. The Centers for
Disease Control and Prevention framework for program evaluation was used to guide the
study. Data were collected using a pretest and posttest with the Clinical Opiate
Withdrawal Scale (COWS) over a 6-month period. Results of t-test analysis indicated a
significant change in drug use (p = .000). Recommendations to clinic administrators
included encouraging all staff to use the COWS in screening individuals and observing
them at each clinic visit. The implication of this study for social change is that findings
may be used to reduce drug abuse and misuse among prescription opioid users.
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Section 1: Nature of the Project
The purpose of this project was to evaluate the impact of a 6-month inner-city
drug treatment (DTBF) program on adults ages 18 to 25 using the Clinical Opioid
Withdrawal Scale (COWS) (see Appendix). The COWS was used to assess the signs and
symptoms of opioid withdrawal before and after participating in the drug treatment
program. Drug abuse is a global epidemic affecting health, wealth, security,
socioeconomic status, violence, and risky sexual behaviors leading to an increase in HIV
and STD incidences (United Nations Office on Drugs and Crime, 2010). The epidemic of
opioid abuse is important to address because of the negative effects on families,
communities, and the United States. Drug abuse affects primarily young adults ages 18 to
25 (Murthy, 2016). In 2015, two million people abused prescription opioids, and about 12
million individuals misused their prescription opioid pain reliever (Murthy, 2016). In
2014, there were 47,055 drug overdose deaths in the United States, and 28,647 (61%)
were from opioids (Rudd, Aleshire, Zibbell, & Gladden, 2016). Drug overdoses in
Maryland resulted in 1,259 deaths in 2015 and 1,468 deaths in 2016 (Maryland
Department of Health and Mental Hygiene, 2017). Prescription and street drugs are
causing the deaths of young adults because of deficient knowledge and drug seeking
behaviors (Volkow, Frieden, Hyde, & Cha, 2014).
The purpose of this project was to evaluate the DTBF program to assist
stakeholders in identifying areas of improvement and to assess the impact of knowledge
acquisition on behavioral changes among opioid users. The goal of the program was to
decrease drug abuse and misuse as measured by a pretest and posttest with the COWS.
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Section 1 presents the problem statement, purpose of the study, nature of the doctoral
project, significance, and summary.
Problem Statement
Young adults often start drug use as a way to be socially connected with friends
or groups of classmates who may be acquaintances. If the drug fills a valuable need, the
abuser may continue using (Robinson, Smith, Saisan, & Shubin, 2017). As drug abuse
takes hold of the abuser, it eventually consumes the abuser’s life.
The purpose of this DNP project was to evaluate the effectiveness of an inner-city
DTBF program. In spite of many community strategies and clinic implementations to
reduce the alarming death rate related to opioid use, young adult drug abusers continue to
experience an increase in the number of cases. The study site experienced a 64% increase
in opioid drug overdose deaths in the first quarter of 2017, jumping from 113 in 2016 to
176 in 2017 (Luttrell, 2017). The clinic developed an education program that included
individual therapy sessions, drug education, and behavior modification education. The
DTBF program welcomes young adults ages 18 to 25 who are using drugs. The program
is facilitated twice a week by two rehabilitation therapists. This DNP project included
pretest and posttest COWS data and de-identified data from the medical clinic records to
compare participants’ knowledge before and after the program. The goal of the DTBF
program was to achieve a safe and comfortable level of physical stability to address the
psychological manifestations of withdrawal (American Addiction Centers, 2015).
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Purpose Statement
The purpose of this project was to evaluate the DTBF program to assist
stakeholders in identifying areas of improvement, to assess the impact of knowledge
acquisition on behavioral changes, and to reduce drug abuse and overdose deaths among
adults ages 18 to 25 through use of the COWS. The project question was the following:
Does participation in the DTBF program result in a decrease in participant-reported
opioid drug use as measured by a pretest and posttest with the COWS? The DTBF
program was open to young adults ages 18 to 25. The program was focused on behavioral
modification enhancement through self-motivation and eagerness to resist old behaviors.
Nature of the Doctoral Project
The nature of this DNP project was an evaluation of the DTBF program and its
effect on the reduction of opioid drug use by young adults in an inner-city medical clinic.
The program evaluation followed the steps outlined for the evaluation of an existing
quality improvement initiative in the DNP Manual for Quality Improvement Evaluation
Projects. The project question was the following: Does participation in the DTBF
program result in a decrease in participant-reported opioid drug use as measured by a
pretest and posttest with the COWS? Databases for the program evaluation search
included PubMed, Cochrane, CINAHL, and Medline. The Google Scholar search engine
was also used.
The COWS consists of 11 assessment questions. Participants completed the
COWS at the first program class (January 2018) and at the final class 6 months later
(June 2018). All pretest and posttest scores of participants who complete at least 85% of
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the program were compared using paired samples t test. De-identified data were provided
by the facility.
Facilitators participating in the DTBF will complete an evaluation of the program.
A report outlining the findings was presented to the clinic administrators and
stakeholders. Recommendations for future programs based on evidence-based practices
was be included.
Significance
The DTBF educational program for opioid drug users focuses on planned
behavior modification that will result in a decrease in opiate drug use among the
participants. The program includes evidence-based strategies for treating drug abusers
including administration of the COWS. The program will help to positively impact the
community by reducing opioid use, increasing cultural empowerment, increasing
socioeconomic status, decreasing violence, and promoting behavioral modification
changes. The DNP project will be important to those participants who volunteered to
participate in the DTBF program by providing data on the effectiveness of the program
and assisting stakeholders in identifying areas of improvement. Medical center staff
responsible for implementation of the DTBF program will be given the opportunity to
give input, evaluate the program, interpret results, disseminate evaluation findings, and
assist stakeholders in identifying areas of improvement.
The key stakeholders include community members and advocates, law
enforcement personnel, drug treatment program staff, and health care professionals. A
decrease in opioid-related visits to the clinic, emergency first facilities, and community
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treatment programs will decrease the burden on the health care system. Findings from the
study may also be used to reduce crime, imprisonment of abusers, and opioid-associated
overdoses. The number of opioid overdoses may be reduced through participation in the
educational program and increased awareness of drug abuse. The program helps to
increase community awareness and reduce deaths from drug abuse in young adults.
Summary
Drug abuse is a severe health epidemic in the inner city where the project was
conducted. The alarming increase in opioid-related deaths and treatment of opioid users
places requires health care providers in the inner city to address and combat drug abuse
problems. The purpose of this project was to evaluate the DTBF program to assist
stakeholders in identifying areas of improvement, to assess the impact of knowledge
acquisition on behavioral changes, and to reduce the use of drug abuse and overdose
deaths among young adults ages 18 to 25 through use of the COWS. The project question
was the following: Does participation in the DTBF program result in a decrease in
participant-reported opioid drug use as measured by a pretest and posttest with the
COWS?
Section 1 introduced the problem and purpose of this project, the nature of the
project and the significance of the project to social change. Section 2 addresses the
concepts, models, and theories that are relevant to nursing practice. Included in Section 2
are local background and context, the role of the DNP student, and role of the project
team.
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Section 2: Background and Context
The DTBF program is administered by an inner-city medical clinic. The team of
workers at the clinic associated with the drug program consists of the program
administrator, counselors, interns, and stakeholders from other programs or services
functioning within the clinic. The patients at the clinic are there voluntarily or court
ordered with drug dependence behavior. Patients demonstrate little to no knowledge of
the medical effects of opioid drugs and the consequences of long-term drug use. The
clinic, which is located in an urban inner city in the southeast United States, observed a
64% increase in opioid drug overdose deaths in the first quarter of 2017, jumping from
113 in 2016 to 176 in 2017 (Luttrell, 2017). The clinic desired a quality assurance effort
to determine whether their DTBF program promotes behavioral changes and leads to a
decrease in drug use among program participants. The purpose of this project was to
evaluate the DTBF program to assist stakeholders in identifying areas of improvement, to
assess the impact of knowledge acquisition on behavioral changes, and to reduce drug
abuse and overdose deaths among young adults through use of the COWS. The project
question was the following: Does participation in the DTBF program result in a decrease
in participant-reported opioid drug use as measured by a pretest and posttest with the
COWS?
Concepts, Models, and Theories
Public health professionals strive to achieve health improvement. In 1999, the
Centers for Disease Control and Prevention (CDC, 2017) developed a framework for
program evaluation to ensure commitment to improving overall community health amidst
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the complex transition in public health to achieve measurable health outcomes. As shown
in Figure 1, there are six steps in the CDC framework: engage stakeholders, describe the
program, focus the evaluation design, gather credible evidence, justify conclusions, and
ensure use and share lessons learned (CDC, 2017).

Figure 1. Conceptual framework of program evaluation in public health (CDC, 1999).
Engage Stakeholders
Public health work involves partnerships; the participants in the evaluation
process for the current project are the inner-city medical clinic staff who are responsible
for implementing the program. Stakeholders must be involved in the process to ensure
that their perspectives are understood. When stakeholders are not fully participating in
the evaluation, the project might not address important elements of the program’s
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objectives, operations, and outcomes. The stakeholder roles include engaging in
progressive inputs about proper evaluation of the participants, evaluating data collection
tools, and interpreting the results.
Describe the Program
The DNP project should follow the mission and objectives of the program being
evaluated (CDC, 2017). The DTBF program includes a clear and brief account of how to
use the COWS to assess the knowledge of young adults regarding the signs and
symptoms of opioid withdrawal.
Focus the Evaluation Design
The evaluation will include comparing the pretest and posttest results and the
inner-city medical clinic archival results. The goal was to evaluate the differences and
note the impact the DTBF program has on participants’ behavior modification.
Gather Credible Evidence
The participant data from the DTBF program from January to June 2018 was
reviewed to determine the impact of the program on the knowledge of young adults
regarding the signs and symptoms of opioid withdrawal. The DTBF program includes
quantitative statistics to evaluate the data. Stakeholders completed evaluation of the
program.
Justify Conclusions
The DTBF program results and recommendations was used to improve the
program and educate more young adults regarding signs and symptoms of opioid
withdrawal.
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Ensure Use and Share Lessons Learned
The DNP findings was communicated to the stakeholders. Recommendations
based on evidence-based practices was included.
Relevance to Nursing Practice
According to the Centers for Disease Control and Prevention (2017), the groups
most commonly affected by opioid abuse are those who have chronic pain conditions and
those who are initially prescribed opioid pain medication for their chronic pain
conditions. This epidemic is a widespread national problem, and opioid abuse occurs in
both urban and suburban communities (Dasgupta, Beletsky, & Ciccarone, 2018).
Dasgupta et al. (2018) stated that in attempts to address this national epidemic, there
remain large health care disparities regarding chronic pain treatment and opioid
addiction. Opioid abuse and overdose with opioid medications are higher in individuals
who have lower socioeconomic status and education levels. Certain minority groups in
the United States are also at a higher risk of opioid use and abuse. According to Dasgupta
et al., “Native Americans are disproportionally affected by overdose deaths as are African
Americans in Illinois, Wisconsin, Missouri, Minnesota, West Virginia, and Washington,
DC, among other places” (p. 184). Over 41% of opioid overdose deaths occur in urban
counties in the United States. Awareness and funding are being made available to combat
this alarming situation.
New pharmacological treatments are becoming available for the worldwide
epidemic of heroin (diamorphine) abuse (Drugs & Therapy Perspectives, 2003). These
treatments include drugs that either reduce opiate withdrawal symptoms during
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detoxification or improve psychosocial equilibrium during maintenance therapy. Oral
methadone maintenance remains the gold standard of pharmacotherapy for heroin
dependence and is also used for managing withdrawal. The long-acting form of
methadone can be administered on a less than daily schedule to patients who fail
methadone maintenance.
Buprenorphine is used for managing withdrawal and maintenance treatment. Both
buprenorphine and naloxone have been introduced as an option for maintenance therapy.
Clonidine and Lofexidine are nonopiate drugs used commonly for management of
withdrawal symptoms. Lofexidine is suitable for use in outpatient settings because it is
associated with fewer adverse effects. A long-acting opiate receptor antagonist,
Naltrexone, has been used to accelerate opiate detoxification and as a maintenance agent.
The medication used for withdrawal has its own side effects.
Wiessing et al. (2017) discussed the historical development of successful
epidemiological indicators of the quality of harm reduction services for monitoring and
evaluation at international, national, and subnational levels. The aim was to improve
these services to reduce health and social problems among people who use drugs, human
immunodeficiency virus (HIV) and hepatitis C virus infection, crime and legal problems,
overdose (death), and other morbidity and mortality. The framework was developed
collaboratively using consensus methods involving nominal group meetings, review of
existing quality standards, frequent e-mail communication, and qualitative analysis of
opinions/experiences from a broad range of professionals/experts, members of civil
society, and organizations representing people who use drugs. Twelve priority candidate
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indicators were proposed for opioid agonist therapy (OAT), needle and syringe programs
(NSP), and generic cross-cutting aspects of harm reduction services. Wiessing et al.
concluded that the best practice indicators for monitoring harm reduction service will
provide a structural basis for public health and epidemiological studies and support
evidence- and human rights-based health policies, services, and interventions. Harm
reduction, such as NSP and OAT, has helped in reducing harm from sharing needles.
According to Samet and Fiellin (2015), the efforts in 90 countries having NSP programs
and 80 having OAT programs have contributed to reductions in viral infections and other
related comorbidities of drug abuse and addiction.
Education, knowledge, and awareness of the signs and symptoms of drug abuse
will encourage users to reduce use. The list and the mechanism of actions of the antidote
of opioid withdrawal medication with the side effect of the Clonidine, lofexidine,
Naltrexone, and Methadone will influence the drug user to reduce using secondary to the
side effect of the antidotes. There are many variants and focuses of opioid withdrawal
education, and that is why a guideline for the practice site was tailored to the target
population. Considerations of the demographics of the target population, including
education levels and cultural factors, were included in the guideline. Self-management
was designed to encourage consumers to manage and notice their withdrawal symptoms,
which will encourage them to be in charge of their health care needs.
According to Brody (2017), of the 23.5 million teenagers and adults addicted to
alcohol or drugs, only about 1 in 10 gets treatment, which often fails to keep them drug
free. Many of these programs fail to use proven methods to deal with the factors that
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underline addiction and set off relapse. According to recent examinations of treatment
programs, most are rooted in outdated methods rather than newer approaches shown in
scientific studies to be more effective in helping people achieve and maintain addictionfree lives. People typically do more research when looking for personal items like a car
than when seeking treatment for drug abuse. Health care providers are on the front line in
disease prevention and treatment of drug addiction. Health care providers understand the
risk factors for drug abuse, screen for risky substance use, intervene when needed, and
diagnose, treat and manage drug abuse just as they do all other diseases (Center on
Addiction, 2012). The COWS has been found to be one of the useful tools doctors and
other health providers use to monitor the severity of withdrawal symptoms. These tools
help in determining the next steps in opiate therapy detoxing treatment. The COWS tool
is crucial because it allows the clinician to determine the time to begin administering the
opiate blocker. If administered too soon, the blocker reacts, and the patient becomes sick
quickly. The COWS is practical and beneficial because it indicates the level of dosing
and how often it is required to maintain patients’ comfort and safety, mostly when opiate
withdrawal problems can worsen medical conditions (Palarinus, 2018).
Nursing Role in Drug Prevention
Manworren and Gilson (2015) proposed nursing roles and interventions in
educating families to reduce the occurrence and potentially fatal consequences of
prescription opioid diversion. Manworren and Gilson presented three potential methods
in which nurses can play a critical role: educating about the risks of opioid diversion,
providing patients with ideas on the safekeeping and proper disposal of opioids, and
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tracking patients’ analgesic use to improve knowledge of prescription analgesic
requirements for pain management. Nurses are in a better position to help reverse the
occurrence and potentially fatal consequences of prescription opioids due to their direct
contact with patients. Manworren and Gilson discussed the magnitude of the problem of
diversion, nonmedical use, and inappropriate storage and disposal of prescription opioids.
Joranson and Gilsn (2005) analyzed Drug Enforcement Administration data from
22 Eastern states between 2000 and 2003 and found that nearly 28 million dosage units of
controlled substances were diverted in those states over that period, with six opioids
(oxycodone, morphine, methadone, hydromorphone, meperidine, and fentanyl)
representing nearly a quarter (roughly 6.5 million) of those dosage units. The National
Institute on Drug Abuse reported that nearly 71% of diverted prescription drugs are
obtained from a friend or relative, either for free (54.2%) or through theft or purchase
(16.6%) (Substance Abuse and Mental Health Services Administration [SAMHSA],
2014). Approximately 2.8 million people ages 12 and older reported using an illicit drug.
About 20% of these cases involved the nonmedical use of prescription drugs, and about
60% of these cases involved pain relievers. Nursing education is designed to reduce drug
abuse.
In 2016, opioid prescriptions and illicit drugs were the main driver of drug
overdose deaths. Opioids were involved in 42,249 deaths in 2016, and opioid overdose
deaths increased to 5 times higher in 2016 than 1999. The five states with the highest
rates of death due to drug overdose were West Virginia (52.0 per 100,000), Ohio (39.1
per 100,000), New Hampshire (39.0 per 100,000), Pennsylvania (37.9 per 100,000), and
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Kentucky (33.5 per 100,000) (Griffiths (2017). This opioid epidemic calls for
interventions from providers and nurses to combat the trends. Griffiths (2017) described
ways that nurses can help reverse the trends through education. Every day, more than
1,000 people are treated in emergency departments for misusing prescription opioids
(Centers for Disease Control and Prevention (CDC 2017). Nurses can play an important
role in reducing opioid overdose deaths by assessing and monitoring patients. In taking
these steps, nurses can also protect themselves from possible legal action stemming from
opioids drugs (Griffiths, 2017).
Screening
Nurses are well trained to detect patients with opioid abuse or misuse by using
screening tools (National Institute on Drug Abuse, 2003). The national Institute on drug
abuse (NIDA) was created to advance science on the causes and the consequences of
drug use and addiction and apply the knowledge to improve individual, patients and
public health. Nurses use the knowledge drive from NIDA to address the most
fundamental and essential question about drug abuse trend. NIDA was a screening tool
use by nurses to screen patient that uses substance. The NIDA-Modified ASSIST tool
was found on the NIDA website https://www.drugabuse.gov/publications/resource-guidescreening-drug-use-in-general-medical-settings/nida-quick-screen. The three steps are:
1. Ask about past year drug use
2. Begin the NIDA-Modified ASSIST: NIDA was a screening tool use by nurses
to screen patient that uses substance
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3. Score the NIDA-Modified ASSIST for illicit and nonmedical prescription
drug use.
Verify before patients begin taking NSAIDs, validate that they are not taking
other anticoagulants, such as aspirin, and check for hepatic or renal impairment. The
procedure to use for this pain management was available from the Institute for Clinical
Systems Improvement (National Institute on Drug Abuse, 2003). The complete
continuing education on courses in pain management was very efficient to nurses.
Nurses need to educate patients about the role of pain medication in their care.
This education should include pain medication options and the reasons why non-opioids
are preferred. Education on how patients will dispose unused opioid medication was very
necessary. If not disposed, it will be kept for future use and in so doing enhancing the
behavior.
Nurses are aware of referring patients to pain management beyond the acute phase
need should be directed to another provider with this expertise (Griffiths, 2017), and
documentation of the referral in the patient’s health record was necessary. Nurses who
assess and monitor patients for withdrawal and treatment of pain are advised to be
mindful of and have respect for their inherent abuse potential. In so doing, this protects
patients from harm and nurses from potential liability. Using the knowledge acquired
from Advance Practice Nursing helps to bridge the gap in creating awareness in patients
who are in urgent need of reducing drug use.
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Teaching Patients About the Risks of Opioid Diversion and Nonmedical Use
Prescription medications should be taken only as prescribed. They should not
be used for reasons other than those for which they are prescribed (for example, opioids
should not be used to induce sleep).
Medications are prescribed for only one person’s use. They should not be used
by anyone other than the patient, even for the same indication. Sharing prescription
medication was not only potentially dangerous, but it was also a federal crime in
violation of the Controlled Substances Act.
Provide controlled substance disposal education. Nurses should instruct
patients to dispose of prescribed narcotics immediately when no longer needed and to
provide information on safe and convenient disposal methods. The Drug Enforcement
Administration identifies certain medications, including opioids, which are harmful
because a single dose can be fatal if taken by someone other than the patient for whom
the medication was originally prescribed. Disposal instructions for narcotics medications
through flushing them down a sink or toilet (Joranson & Gilsn, 2005).
Track opioid use. Nurses track opioid use through the following:
•

real-time data submission,

•

data access at the point of care,

•

integration with the electronic health record,

•

interstate data sharing,

•

expanded user access to data including the authorization of delegates,

•

data security and confidentiality maintenance,
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•

user education, and

•

development of valid patient risk scoring methods (Joranson & Gilsn, 2005).

Inner City Treatment Program
The inner-city treatment house was unique because it involves the following:, the
individualized treatment, caring for co-occurring disorders, family involvement, and
continuing care after Rehab and holistic philosophy of treatment. Research has shown
that successful programs have specific features in common, like personalized treatment
plans and evidence-based care. Incorporating drug use with the appropriate services was
the key to a successful, long-term recovery in the inner-city treatment center. The
treatment program was made to satisfied drug users experience, which will likely to
promote compliance and desire to complete the program and transfer to a healthy
lifestyle.
Individualized treatment. Previously, all people seeking addiction treatment
received same services at the rehab facility. The treatment involved all spectrum of life,
adult, adolescent, man, woman, were assigned to the same therapies. The individual who
could have been diagnosed with schizophrenia, addiction, and co-occurring disorders
were expected to go through the same rehab without any specialized care for their mental
health condition. The inner-city treatment center provides a personalized treatment. The
program treats each client as an individual, with a unique history and specific needs. The
treatment developed a personalized care plan which begins with a complete evaluation of
the prospective individual before the admission.
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Care for co-occurring disorders. The treatment involves psychiatric conditions
and addiction because the two frequently occur together in patients, this treatment center
recognizes the phenomenon and provide integrated care for their patients with cooccurring disorders. It was vital to screen for a co-occurring mental health disorder to get
connected with a good treatment program.
Family involvement. The involvement with family members and excellent
support system make the program useful. Without the support and participation of family
members, chances of success at rehab are significantly reduced (Michael house treatment
center, 2018).
Continuing care after rehab. What makes the program unique was the
continuation of care after rehab. The program ensures that rehab graduates have the
support they need to stay sober after leaving the secure, structured environment of the
inner- city program.
Holistic philosophy of treatment. The inner-city treatment program, care for
individuals holistically, the center considers the patients entire being when implementing
a recovery plan. The holistic philosophy of care increases the chances of success in
helping heal on all levels. Inner-city treatment house is exceptionally equipped to offer
holistic drug treatment. The program treated each individuals as worthy of dignity,
compassion, and respect.
Prescription drug monitoring. Another successful community program was the
prescription drug monitoring programs (PDMPs). The aim of PDMPs are geared towards
primary prevention to monitor improper prescription of opioid painkillers which was a
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primary upstream driver of opioid epidemic while ensuring critical pain issue was address
as necessary (Davis, Green, & Beletsky, 2017; Volkow et al., 2014). PDMPs are
promising tool for health care provider to see patients prescribing histories to inform their
prescribing decisions. The drug users, shop pain medications from one physician to
another with the aim to misuse medication. The use of PDMPs help to reduce the overly
prescription of pain pills (Davis, C. et al., 2017). In Rhode Island, they adopted PDMPs,
three years later, their opioid overdose deaths dropped by one-third.
Local Background and Context
The state where the inner-city medical clinic was located experienced a 67%
increase in opioid drug associated overdose deaths in 2017 (Maryland Department of
Health and Mental Hygiene, 2017). The DNP project was chosen based on the need of
the patients at the project site and the alarming increase in young adult abuse of drugs.
The inner-city medical clinic was comprised of an administrator, psychiatrist, two
counselors, and a house specialist. The clinic has a population of 30 to 45 participants
who come for therapy. The demographic makeup of the patients is estimated to be 50%
Caucasian, 45% African American, 3% Hispanic, and 1% Asian American. Their
population was both young and old adults, males, females, and all races. The issue being
addressed in this project was the effect of opioid abuse in young adults aged 18 to 25 in
the inner-city medical clinic. The program was held every Tuesday and Thursday, and
two rehabilitation therapists facilitate the program. The program starts at 9:00 a.m. and
ends at 2:00 p.m. The inner-city medical clinic was using the DTBF program to reach out
to the participants who need help with reducing drug use by using methodologies such as
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the medication-assisted treatment (MAT) program, prescription drug monitoring program
(PDMP), and training the neighbors, police officers, and communities on how to apply
Narcan antidote for opioid overdoses to consumers in the community.
Addressing the following was recommended by the American Public Health
Association (2015). Regulate prescription pain medication, and review and revise
prescription drug monitoring laws, doctor shopping laws, and physical and mental status
examination laws. Implement tamper-resistant prescription form requirements,
prescription drug overdose emergency response immunity, and provide access to
Naloxone (American Public Health Association, 2015).
Even with new legislative policy changes, community education energies could
be centered on ensuring safe storage, use, and disposal of prescription medications.
Individuals taking prescription pain medication must be educated on the identification
and treatment of pain. In addition, alternative pain treatment, substance abuse screening,
and mental illness assessment and treatment for vulnerable populations must be provided.
Role of the DNP Student
I observed in this clinic as part of my DNP practicum. The medical director
expressed that the clinic’s goal was not only to provide needed services to the
community, but to ensure that the services provided were implemented effectively both in
cost and desired outcomes. She instituted the DTBF program, and as part of her quality
improvement focus, requested an evaluation of the program. My role as the DNP student
was to complete the program evaluation.
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Role of the Project Team
There are 45 participants in the program. The program facilitator administered the
COWS and provide de-identified data to me for the program evaluation.
Summary
The relevance of this project to nursing practice was the assessment of the drug
program implementation at the inner-city medical clinic to reduce opioid drug abuse,
preventing opioid abuse overdose, decreasing frequent visits to emergency facilities for
pain relief and opioid type medication, and the prevention of pain medicine addictions.
As an evaluation of the drug program and the outcome of this project, the DTBF drug
program can be implemented throughout the inner-city medical clinic, even in the school
system reaching youth as young as age 12. The nurse practitioner can see cost-effective
results through the reduction of opioid related caseloads, medication theft and misuse,
and premature death of young adults aged 18-25 by overdose of opioid drugs. As a
quality assurance effort, the nurse practitioner can build on their drug program by
strengthening weak areas of program delivery services.
Section 2 describes the CDC Program Evaluation for Public Health Model and the
application of the model to this project. The evidence-based literature relevant to the
project was discussed. My role and the role of the facilitator are described. Section 3
discusses the sources of the evidence provided by the facility, participants, procedures,
and protections, and the analysis and synthesis for the project.
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Section 3: Collection and Analysis of Evidence
The DNP project study addressed the effects of opioid abuse in young adults ages
18 to 25 in a medical clinic located in an inner city. Section 3 includes the sources of
evidence provided by the facility. I also describe the participants, procedures, and
protections, and present the analysis and synthesis for the project.
Practice-Focused Question
The purpose of this project was to evaluate the DTBF program to assist
stakeholders in identifying areas of improvement, to assess the impact of knowledge
acquisition on behavioral changes, and to reduce drug abuse and overdose deaths among
young adults through use of the COWS. The project question was the following: Does
participation in the DTBF program result in a decrease in participant-reported opioid drug
use as measured by a pretest and posttest with the COWS.
Sources of Evidence
The inner-city clinic staff retrieved data from the information center using
Amazing chart information technology system with the assistance of medical records
personnel and authorized by the owner and medical director of the inner-city medical
center.
Participants
The inner-city medical clinic has a population of up to 45 participants who come
for therapy. The population was composed of 50% White, 45% African American, 3%
Hispanic, and 1% Asian American. Participants in this project must
•

have experienced using opioid drugs or opioid pain medicine;
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•

have been between the ages of 18 and 25;

•

have been enrolled in the DTBF drug education program held at the inner-city
medical clinic; and

•

have taken an assessment test on their knowledge of drug addiction and
withdrawal, and scored 80 or below.

Procedures
The program evaluation was completed using the steps for the evaluation of
existing quality improvement initiatives outlined in the DNP Manual for Quality.
Qualifying participants were selected and given the COWS (Appendix A) before
attending the 6-month DTBF program and again after completion of the DTBF program.
The COWS was available on the Internet and may be copied and used clinically. Deidentified data were provided to me from the program facilitator. Data will be stored in a
locked cabinet at the facility for a period of 3 years after the program evaluation is
completed. A paired samples t test using SPSS was conducted on the data as well as the
total mean for pretest and posttest data. Participants also completed an evaluation of the
program. Results were reviewed and used for quality improvement recommendations.
Protections
A site approval letter for quality improvement doctoral projects from the DNP
Manual for Quality Improvement Evaluation Projects was obtained from the clinic
administrator. The signed site approval letter and completed institutional review board
(IRB) application was submitted to the (Walden University IRB).
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Analysis and Synthesis
The data analysis included a paired samples t test and review of the program
evaluations. Pretest and posttest data were analyzed to determine whether education on
the signs and symptoms of opioid withdrawal using the COWS made a significant
difference (p = .05).
Summary
The purpose of this project was to evaluate the DTBF program to assist
stakeholders in identifying areas of improvement, to assess the impact of knowledge
acquisition on behavioral changes, and to reduce the drug abuse and overdose deaths
among young adults through use of the COWS. The project question was the following:
Does participation in the DTBF program result in a decrease in participant-reported
opioid drug use as measured by a pretest and posttest with the COWS? Section 3
identified the data used for this program evaluation, including the participants,
procedures, protections, and how the data were analyzed and reported.
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Section 4: Findings and Recommendations
The effects of drug abuse on young adults ages 18 to 25 are alarming (Murthy,
2016). In 2015, two million people abused prescription opioids, and about 12 million
individuals misused their prescription opioid pain reliever (Murthy, 2016). Drug abuse
affects mostly young adults ages 18 to 25. The epidemic is comprehensive, affecting
young and old, male and female (Murthy, 2016). The drug abuse crisis has claimed many
lives in the study site community with social and economic impacts to the area. Volkow
et al. (2014) reported that prescription and street drugs are causing the deaths of young
adults because of insufficient knowledge and drug-seeking behaviors.
The purpose of this project was to evaluate the DTBF program to assist
stakeholders in identifying areas of improvement, to assess the impact of knowledge
acquisition on behavioral changes, and to reduce the drug abuse and overdose deaths
among young adults through use of the COWS. Social change implications include a
decreased number of opioid overdoses resulting from individuals participating in the
educational program and increasing their awareness of drug abuse.
Findings and Implications
The objective of this project was to answer the following question: Does the
knowledge of signs and symptoms of opioid withdrawal from participating in the DTBF
program result in a significant behavioral change of opioid abuse in young adults ages 18
to 25 as measured by a pretest and posttest with the COWS? Results of a paired samples t
test (N = 45) revealed a significant change in the results of the COWS survey at a 95%
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confidence level. This result indicated a significant improvement in drug use behavior
among participants, as shown in Table 1.
Table 1
Paired Samples T Test
________________________________________________________________________
Mean Std. Deviation Std. Error Mean Lower

Upper

t

6.111 5.74146

7.83604

7.140 44

.85589

4.38618

df

Sig (2-tailed)
.000

Recommendations
The rising prevalence of opioid drug abuse and overdose was causing a significant
threat to the population in and around the inner-city community. The clinic should train
all staff members to use the COWS in screening patients and observing them at every
visit. Clients who demonstrate little or no improvement in their COWS scores can be
offered pain management treatment over prescribed pain medicine.
Strengths and Limitations of the Project
The inner-city clinic staff participated in the project and acted independently from
any external influences; there was no conflict of interest. The project included evidencebased recommendations from accredited organizations such as the Centers for Disease
Control and Prevention and SAMHSA. The COWS instrument is a reliable and valid tool
that can be easily administered at each client encounter. The strengths of the project
included a large number of respondents; 45 of 45 participants responded. The location of
the project site was centralized, which enhanced access to transportation. The formative
group and summative group included patients who were court committed and health care
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counselors who had several encounters with opioid abuse. Participants who were not
health care providers contributed knowledge from the layperson’s point of view, gave
suggestions on how to improve the wording and formatting of opioid management
education, and provided recommendations on the method of implementation.
Although the COWS was a useful tool, drug use was a complex phenomenon, and
the COWS tool may not be robust enough to explain complex issues. The time duration
was limited, from January to June 2018. One of the problems of the study was to
maintain 80% attendance required for eligibility. Some participants came late to the
program because of transportation issues. The sample size was limited and there was no
follow-up after the 6-month period.
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Section 5: Dissemination Plan
The purpose of this project was to evaluate the impact of a 6-month inner-city
DTBF program for young adult ages 18 to 25 using the 11 items of the COWS
instrument. Comparison of pretest and posttest data revealed a significant difference in
the scores of the COWS. The project and the results of the COWS was presented to the
clinic providers. The presentation occurred during the midday. The presentation included
charts, posters, graphs, data, and samples of the questionnaires.
Analysis of Self
The nursing profession involves engagement in the development and promotion
of new approaches to nursing practice. Because of the alarming rate of opioid abuse rate
in the inner city, I conducted this study to reduce the number of deaths related to opioid
drug abuse and misuse. As a DNP student, I have a duty to advance the practice of
nursing, provide the possible best treatment to patients, and improve consumers’ health
outcomes through evidence-based treatment guidelines. My knowledge of the DTBF
project will greatly assist the stakeholders in identifying areas of improvement, assessing
the impact of DTBF program on behavioral changes, and planning long-term professional
health care policies. My knowledge of the DTBF project will lead to a more
comprehensive assessment of health issues in a complex and large health care institution.
I applied scholarly methodology with the goal of improving health care outcomes,
improving an organizational process, improving workplace and consumer satisfaction,
and implementing health care policies to promote education regarding opioid use.
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I supported the staff, counselors, facilitators, and interns in collaborating with
stakeholders to implement the new practice change.
Summary
The purpose of this DNP project was to improve a practice within an organization
and to gain insight in the effectiveness of the practice change. The DTBF project was
effective because of the moderate impact on consumers’ behavior regarding opioid drug
use. The outcome of the project was disseminated through poster presentations and visual
presentations.
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Appendix: Clinical Opiate Withdrawal Scale
For each item, circle the number that best describes the patient’s signs or symptom. Rate on just the
apparent relationship to opiate withdrawal. For example, if heart rate is increased because the patient
was jogging just prior to assessment, the increase pulse rate would not add to the score

Resting Pulse Rate:
beats/minute
Measured after patient is sitting or lying for one minute
0 pulse rate 80 or below
1 pulse rate 81- 1 00
2 pulse rate 1 0 1 - 1 20
4
rate
than 1 20

Sweating: over past 1/2 hour not accounted forby
room temperature or patient activity.
0 no report of chills or flushing
1 subjective report of chills or flushing
2 flushed or observable moistness on face
3 beads of sweat on brow or face
4 sweat
off face

GI Upset: over last 1/2 hour
0 no GI symptoms 1
stomach cramps
2 nausea or loose stool
3 vomiting or diarrhea
5
of diarrhea or

Tremor observation of outstretched hands
0 no tremor
1 tremor can be felt, but not observed
2 slight tremor observable
4 gross tremor or muscle twitching

Restlessness Observation during assessment

Yawning Observation during assessment

0 able to sit still
1 reports difficulty sitting still, but is able to do so
3 frequent shifting or extraneous movements of legs/arms
5 unable to sit still for more than a few seconds

0 no yawning
1 yawning once or twice during assessment
2 yawning three or more times during assessment
4
several times/minute

Pupil size

Anxiety or Irritability

0 pupils pinned or normal size for room light
1pupils possibly larger than normal for room light
2 pupils moderately dilated
5 pupils so dilated that only the rim of the iris is visible

0 none
1 patient reports increasing irritability or anxiousness
2 patient obviously irritable or anxious
4 patient so irritable or anxious that participation in the
assessment is difficult

Bone or Joint aches if patient was having pain
previously, only the additional component attributed
to opiates withdrawal is scored

Gooseflesh skin

0 not present
1mild diffuse discomfort
2 patient reports severe diffuse aching of joints/muscles
4 patient is rubbing joints or muscles and is unable to sit still
because of discomfort

0 skin is smooth
3 piloerection of skin can be felt or hairs standing up
on arms
5 prominent piloerection

Runny nose or tearing Not accounted for by cold
-symptoms or allergies
0 not present
1nasal stuffiness or unusually moist eyes
2 nose running or tearing
4 nose constantly running or tears streaming down cheeks

Total Score
The total score is the sum of all 1 1 items
Initials of person
completing assessment:

Score: 5- 12 = mild; 13-24 = moderate; 25-36 = moderately severe; more than more than 36 = severe withdrawal this version
may be copied and used clinically.

